Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A McKinlay

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Preventive Medicine|August 19, 2015
Immunization EquityAlan R Hinman, Mark A McKinlay
Vaccine|November 29, 2015
Immunization equityAlan R Hinman, Mark A McKinlay
Vaccine|December 4, 2018
Global Funders Consortium for Universal Influenza Vaccine DevelopmentJoseph S Bresee, Mark A McKinlay, Jon Abramson, et al.
Biochemical and Biophysical Research Communications|June 20, 2014
Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosisCarolyn M Gray, Kelly A McCorkell, Srinivas K Chunduru, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirusesDaniel C Pevear, Frederick G Hayden, Tina M Demenczuk, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 25, 2010
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonistThomas S Griffith, Tamara A Kucaba, Michael A O'Donnell, et al.
Vaccine|February 27, 2018
New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of dataMohammadreza Shaghaghi, Saeed Soleyman-Jahi, Hassan Abolhassani, et al.
Vaccine|July 22, 2019
The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plansMichael A Daugherty, Alan R Hinman, Stephen L Cochi, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
The Journal of Infectious Diseases|December 10, 2016
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge ModelMarc S Collett, Jeffrey R Hincks, Kimberley Benschop, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Preventive Medicine|August 19, 2015
Immunization EquityAlan R Hinman, Mark A McKinlay
Vaccine|November 29, 2015
Immunization equityAlan R Hinman, Mark A McKinlay
Vaccine|December 4, 2018
Global Funders Consortium for Universal Influenza Vaccine DevelopmentJoseph S Bresee, Mark A McKinlay, Jon Abramson, et al.
Biochemical and Biophysical Research Communications|June 20, 2014
Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosisCarolyn M Gray, Kelly A McCorkell, Srinivas K Chunduru, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirusesDaniel C Pevear, Frederick G Hayden, Tina M Demenczuk, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 25, 2010
Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonistThomas S Griffith, Tamara A Kucaba, Michael A O'Donnell, et al.
Vaccine|February 27, 2018
New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of dataMohammadreza Shaghaghi, Saeed Soleyman-Jahi, Hassan Abolhassani, et al.
Vaccine|July 22, 2019
The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plansMichael A Daugherty, Alan R Hinman, Stephen L Cochi, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
The Journal of Infectious Diseases|December 10, 2016
Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge ModelMarc S Collett, Jeffrey R Hincks, Kimberley Benschop, et al.
Pageof 2